Edward Pavillard, DO
Vascular Surgery · Limerick, PANPI 1548222979
Payments from drug & device makers
Across 718 payments — averaging $94.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$30K
- Imperative Care, Inc$13K
- Medtronic$5K
- Shockwave Medical, Inc$4K
- Penumbra, Inc.$3K
- Cagent Vascular Inc$3K
- plus $9K from 30 others
What the payments were for
- Consulting fees$27,05640%
- Speaking & faculty fees$25,25037%
- Travel & lodging$3,7186%
- Food & beverage$11,46617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 24 | $30,339 |
| Imperative Care, Inc | 16 | $13,332 |
| Medtronic(2 entities) | 69 | $4,596 |
| Shockwave Medical, Inc | 23 | $4,034 |
| Penumbra, Inc. | 17 | $3,294 |
| Cagent Vascular Inc | 5 | $3,129 |
| Avinger Inc. | 42 | $2,482 |
| Cordis US CORP. | 314 | $2,305 |
| Cardinal Health 200 LLC | 123 | $827 |
| Vesalio, Inc. | 1 | $750 |
| W. L. Gore & Associates, Inc. | 19 | $554 |
| Bard Peripheral Vascular, Inc. | 19 | $337 |
| Truvic Medical, Inc. | 5 | $282 |
| Cook Medical LLC | 1 | $145 |
| Boston Scientific | 5 | $136 |
| Endologix LLC | 2 | $106 |
| BD | 2 | $97 |
| Johnson & Johnson(2 entities) | 5 | $91 |
| Z-medica, LLC | 2 | $81 |
| Inari Medical, Inc. | 1 | $70 |
| Cardiovascular Systems Inc. | 3 | $69 |
| Sanara Medtech Inc. | 3 | $59 |
| Lemaitre Vascular, Inc. | 3 | $55 |
| Silk Road Medical, Inc. | 1 | $52 |
| Smith+Nephew | 2 | $41 |
| Angiodynamics, Inc. | 1 | $34 |
| Abbott | 1 | $25 |
| Next Science LLC | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Teleflex LLC | 1 | $22 |
| KCI USA, Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $14 |
| Davol Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOOM 88-T LARGE DISTAL PLATFORM$12,825
- IGT D Peripheral$12,800
- (9520) IGT Devices Undivided$10,617
- Spectranetics Undiv$6,400
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,339
- Indigo$3,104
- Serrantor$3,000
- Valiant Captivia$2,232
- PANTHERIS$1,323
- ENDURANT IIS$794
- NA$292
- Zilver PTX$145
- Turbo Elite$131
- PRODIGY CATHETER$116
- (6578) Visions 018$115
How this compares
$67,491 in reported general payments places this provider in the 90th percentile of 236 vascular surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 50 | $36,612 |
| EliquisApixaban | 35 | $30,879 |
| ClopidogrelClopidogrel Bisulfate | 224 | $1,986 |
| Atorvastatin Calcium | 15 | $429 |
| Cilostazol | 18 | $253 |
| Warfarin Sodium | 16 | $198 |
| Amlodipine Besylate | 14 | $124 |
| Pantoprazole Sodium | 23 | $107 |
| Tramadol Hcl | 24 | $67 |
| Oxycodone Hcl | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $91 | $36,61250 claims |
| PfizerEliquis | $15 | $30,87935 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 236 vascular surgery providers in Pennsylvania.
Other vascular surgery in Limerick
- Darren SchneiderPhiladelphia$1M
- Nathan LiangPittsburgh$551K
- Elizabeth GenovesePhiladelphia$475K
- Shang LohPhiladelphia$350K
- Meghan DermodyLancaster$321K
- Paul FoleyDoylestown$257K
- Michel MakarounPittsburgh$241K
- Edward WooPhiladelphia$189K
- Paul DimuzioPhiladelphia$177K
- Grace WangPhiladelphia$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.